Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2026-07-01 @ 1:12 AM
Study NCT ID:
NCT05602935
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-28
First Post:
2022-10-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
Sponsor:
The Second Affiliated Hospital of Fujian Medical University
Organization:
Conditions & Keywords Data
Conditions: